VEGFR-3 Expression in Lymphatic Endothelial Cells from Lymphangiomas
Author Information
Author(s): Norgall Susanne, Papoutsi Maria, Rössler Jochen, Schweigerer Lothar, Wilting Jörg, Weich Herbert A
Primary Institution: Helmholtz Centre for Infection Research, Braunschweig, Germany
Hypothesis
Do lymphatic endothelial cells from lymphangiomas express different levels of molecular markers compared to those from healthy tissues?
Conclusion
Lymphatic endothelial cells from lymphangiomas show variable expression of markers but consistently express Prox1, with elevated levels of VEGFR-3 suggesting a role in lymphangioma development.
Supporting Evidence
- LECs from lymphangiomas express Prox1, distinguishing them from blood endothelial cells.
- High levels of VEGFR-3 and VEGFR-2 were found in lymphangioma LECs.
- Expression profiles of LECs from lymphangiomas were compared to those from healthy tissues.
Takeaway
This study looked at cells from children with lymphangiomas and found that they have special markers that help identify them, which might help understand and treat these conditions better.
Methodology
Cells were isolated from lymphangioma tissues using FACS sorting and characterized through various immunological methods.
Potential Biases
Potential bias in the selection of tissue samples and the methods used for cell isolation.
Limitations
The study is limited by the small sample size and the variability in marker expression among different lymphangioma tissues.
Participant Demographics
Two male patients aged 10 and 4 months with lymphangiomas located in the axillary and upper arm regions.
Statistical Information
P-Value
0.000114
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website